Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
1,269,855
-
Share change
-
-12,163
-
Total reported value
-
$48,887,021
-
Price per share
-
$38.50
-
Number of holders
-
7
-
Value change
-
-$472,713
-
Number of buys
-
3
-
Number of sells
-
2
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q2 2024
As of 30 Jun 2024 GLAXOSMITHKLINE PLC - ADR (GSK) had 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,269,855 shares of stock of the company.
Largest 7 holders included KAHN BROTHERS GROUP INC, EAGLE ASSET MANAGEMENT INC, Columbia Asset Management, PARADIGM ASSET MANAGEMENT CO LLC, PARK CIRCLE Co, Byrne Asset Management LLC, and HUNTINGTON NATIONAL BANK.
This table shows 7 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.